Vitamin D and Risk of Cardiovascular and Non-Cardiovascular Mortality: A Prospective Cohort Study and Meta-Analysis od Emberson, JR, Tomson, J, Hill, M, Armitage, J, Leon, D, Fletcher, A, Collins, R, Clarke, R

Vitamin D and risk of death from vascular and non-vascular causes in the Whitehall study and meta-analyses of 12,000 deaths. od Tomson, J, Emberson, J, Hill, M, Gordon, A, Armitage, J, Shipley, M, Collins, R, Clarke, R

Effects of extended-release niacin with laropiprant in high-risk patients. od Landray, M, Haynes, R, Hopewell, J, Parish, S, Aung, T, Tomson, J, Wallendszus, K, Craig, M, Jiang, L, Collins, R, Armitage, J

Effects of extended release niacin/laropiprant in 25,673 high-risk individuals receiving statin-based therapy: the HPS2-THRIVE randomized placebo-controlled trial od Landray, M, Haynes, R, Hopewell, J, Parish, S, Aung, T, Tomson, J, Wallendszus, K, Craig, M, Jiang, L, Landray, M, Collins, R

Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care od Hin, H, Tomson, J, Newman, C, Kurien, R, Lay, M, Cox, J, Sayer, J, Hill, M, Emberson, J, Armitage, J, Clarke, R

Effects of vitamin D on blood pressure, arterial stiffness, and cardiac function in older people after 1 year: BEST‐D (Biochemical Efficacy and Safety Trial of Vitamin D) od Tomson, J, Hin, H, Emberson, J, Kurien, R, Lay, M, Cox, J, Hill, M, Arnold, L, Leeson, P, Armitage, J, Clarke, R